Concord Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Dec' 22

Sales

318.97

240.80

262.35

194.83

240.68

Operating profit

134.29

105.93

119.19

72.15

111.68

Interest

0.46

0.50

0.84

0.75

0.91

Gross profit

144.64

113.62

126.47

78.05

120.02

EPS (Rs)

9.29

7.13

8.08

4.63

7.56

Other income

10.81

8.19

8.13

6.65

9.25

Stock adjustment

21.73

-23.52

0.39

-10.67

-1.47

Raw material

55.67

47.39

42.00

39.48

43.36

Power and fuel

-

-

-

-

-

Employee expenses

33.96

30.67

30.17

28.25

27.54

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

73.33

80.33

70.60

65.62

59.57

Provisions made

-

-

-

-

-

Depreciation

13.72

13.54

13.30

13.04

13.77

Taxation

33.70

25.53

28.68

16.54

27.17

Net profit / loss

97.21

74.55

84.49

48.47

79.08

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.46

10.46

10.46

10.46

10.46

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

42.10

43.99

45.43

37.03

46.40

GPM (%)

43.86

45.63

46.76

38.74

48.02

NPM (%)

29.48

29.94

31.24

24.06

31.64